Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Annexin 1 (
ANXA1
) is a key mediator of the inhibitory effects of glucocorticoids on
adrenocorticotropic hormone (ACTH)
release, which develop within 1-2 h of a steroid challenge. Our previous studies, which showed that (i)
ANXA1
is expressed principally by the nonsecretory folliculo-stellate cells in the pituitary gland; (ii) glucocorticoids cause the exportation of
ANXA1
from these cells; and (iii) corticotrophs express specific
ANXA1
binding sites, led us to propose that
ANXA1
serves as a paracrine or juxtacrine mediator of glucocorticoids. To address this hypothesis, we examined
ANXA1
-dependent glucocorticoid actions in co-cultures of murine corticotroph (AtT20 clone D1) and folliculo-stellate (TtT/GF) cell lines.
ANXA1
mRNA and protein were found in abundance in TtT/GF cells but neither was detectable in the AtT20 cells. AtT20 cells (alone and in co-culture with TtT/GF cells) responded to
corticotropin
-releasing hormone (CRH) (0.1-1 micro m) with increased ACTH release. The CRH-stimulated release of ACTH from AtT20 cells cultured alone was unaffected by preincubation with dexamethasone (Dex, 100 nm); by contrast, in co-cultures of AtT20 and TtT/GF cells, the steroid readily inhibited the secretory response to CRH. The effects of Dex on ACTH release were mimicked by N-terminal
ANXA1
fragments (ANXA1Ac2-26, 2 micro g/ml and ANXA11-188, 0.1 ng/ml) and reversed by mifepristone (1 micro m) and by an antisense oligodeoxynucleotide (ODN) to
ANXA1
(50 nm) but not by control ODNs. The antisense ODN also specifically blocked the Dex-induced externalization of
ANXA1
from TtT/GF cells. Immunofluorescence imaging of the co-cultures localized the exported protein to the vicinity of the AtT20 cells and identified
ANXA1
binding sites on these cells. These results provide functional and histological evidence to support our premise that the early inhibitory effects of glucocorticoids on ACTH release are dependent upon paracrine/juxtacrine actions of
ANXA1
derived from folliculo-stellate cells.
...
PMID:Evidence from studies on co-cultures of TtT/GF and AtT20 cells that Annexin 1 acts as a paracrine or juxtacrine mediator of the early inhibitory effects of glucocorticoids on ACTH release. 1463 75
Annexin 1 (
ANXA1
) is a member of the annexin family of phospholipid- and calcium-binding proteins with a well demonstrated role in early delayed (30 min to 3 h) inhibitory feedback of glucocorticoids in the pituitary. We have examined corticotrophs in wild-type and
ANXA1
knockout mice to determine the effects of lack of
ANXA1
in male and female animals. Anterior pituitary tissue from
ANXA1
wild-type, heterozygote and null mice was fixed and examined (i) by confocal immunocytochemistry to determine the number of corticotrophs and (ii) by electron microscopy to examine the size, secretory granule population and secretory machinery of corticotrophs. No differences in these parameters were detected in female mice. In male
ANXA1
null mice, there were approximately four-fold more corticotrophs than in wild-type animals. However, the corticotrophs in
ANXA1
null mice were smaller and had reduced numbers of secretory granules (the reduction in granules paralleled the reduction in cell size). No differences in the numerical density of folliculo-stellate, gonadotroph, lactotroph or somatotroph cells were detected in male
ANXA1
null mice. Plasma corticosterone, adrenocorticotrophic hormone (ACTH) and pituitary pro-
opiomelanocortin
mRNA were unchanged but pituitary ACTH content was increased in male
ANXA1
null mice. Interleukin (IL)-6 pituitary content was significantly elevated in male and reduced in female
ANXA1
null mice compared to wild-type. In conclusion, these data indicate that
ANXA1
deficiency is associated with gender-specific changes in corticotroph number and structure, via direct actions of
ANXA1
and/or indirect changes in factors such as IL-6.
...
PMID:Lack of annexin 1 results in an increase in corticotroph number in male but not female mice. 1702 33